Open AccessExpression of Concern: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection
Author(s) -
AUTHOR_ID
Publication year - 2020
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0240965
Subject(s) - vitamin d and neurology , covid-19 , medicine , adverse effect , calcifediol , vitamin , vitamin d deficiency , virology , outbreak , disease , infectious disease (medical specialty)